 | | | | The European Union will extend a mechanism to monitor and potentially limit the export of COVID-19 vaccines from the bloc until the end of 2021 from the current deadline of end-September, an EU official said on Wednesday. | | | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. | | | | | | Brazil's Butantan biomedical institute is in talks to sell a locally manufactured COVID-19 vaccine developed by China's Sinovac to other countries in South America and Africa, as the federal government has not ordered more of the shots. | | | | | | Pharmacy chain Walgreens Boots Alliance Inc is considering an acquisition of healthcare IT firm Evolent Health Inc , Bloomberg News reported on Wednesday, citing people familiar with the matter. | | | | | | President Joe Biden took aim on Thursday at vaccine resistance in America, announcing policies requiring most federal employees to get COVID-19 vaccinations and pushing large employers to have their workers inoculated or tested weekly. | | | | | | A U.S. federal judge temporarily blocked a key aspect of a new Arizona abortion law that would have allowed felony charges to be laid against doctors for terminating a pregnancy solely on the basis of a hereditary abnormality in the fetus. | | | | | | Poland sent over 100,000 doses of the AstraZeneca COVID-19 vaccine to Egypt, the Polish foreign ministry said on Wednesday. | | | | | | Mirum Pharmaceuticals Inc said its drug became the first U.S. approved therapy for treating itching in patients with rare liver disorder Alagille syndrome (ALGS), and would be available for distribution immediately. | | | | | | The U.S. Centers for Disease Control and Prevention on Wednesday issued a health advisory to increase COVID-19 vaccinations among women who are pregnant, recently pregnant or trying to become pregnant, to prevent serious illness and death. | | | | | | U.S. health regulators' decision on whether to approve Pfizer and BioNTech's COVID-19 vaccine for children ages 5 to 11 could spill over into November if needed, the nation's top u.s. infectious disease official said on Wednesday. | | | | | |
